Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Oncology

Search Medical Condition
Please enter condition
Please choose location

Spinal Cord Malignancy Clinical Trials

A listing of Spinal Cord Malignancy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (6) clinical trials

You are being asked to take part in this research study because you have cancer that has spread to your spine and is causing pain. Multiple radiation treatments are frequently used to treat pain caused by cancer that has spread to the spine. Image-guided radiosurgery/stereotactic body radiation therapy (SBRT) is ...

Phase N/A

Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)

SBRT (Stereotactic Body Radiation Therapy) is a radiotherapy treatment which involves the delivery of a single high dose radiation treatment or a few fractionated radiation treatments (usually up to 5). A high potent biological dose of radiation is delivered to the tumor improving the cure rates for the tumor, in ...

Phase N/A

Natural History of and Specimen Banking for People With Tumors of the Central Nervous System

Background This protocol is designed to meet an unmet need in neuro-oncology by evaluating patients with CNS tumors throughout their disease course. The protocol will evaluate patients with tumors of the central nervous system (CNS) who appear to be probable candidates for future protocol entry, have disease manifestations that are ...

Phase N/A

Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks

In Paris, France, home hospice care for terminally ill patients is organized by four "palliative care networks". These networks are responsible for information sharing and coordination of all health care professionals working with the patient. Two different systems are in place to ensure continuity of care outside working hours, in ...

Phase N/A

Northern Sweden Health and Disease Study

The overall aim of the NSHDS is to support frontline research with particular emphasis on improving diagnostic tools for clinical use, as well as finding early markers of disease, using the blood samples, tissue and associated health data from the NSHDS. Furthermore, basic research regarding risk factors as well as ...

Phase N/A

Patients are needed to participate in a clinical research study evaluating Gemcitabine, sonidegib, trametinib, ribociclib for the treatment of Refractory Brain Tumor, Medulloblastoma, PTCH1 Mutation, Meningioma, Ependymoma, Recurrent, Medulloblastoma, SHH-activated and TP53 Mutant, Pediatric Brain Tumor, Pleomorphic Xanthoastrocytoma, Anaplastic, Glioma, Recurrent Malignant, Malignant neoplasm of brain, Central Nervous System Neoplasms, Germ cell tumor, Embryonal Tumor of CNS, Medulloblastoma, Non-WNT/Non-SHH, CNS Embryonal Tumor With Rhabdoid Features, Medulloblastoma; Unspecified Site, Oligodendroglioma, Neuroectodermal Tumor, Anaplastic Ganglioglioma, Ependymoma, RELA Fusion Positive, Ganglioneuroblastoma of Central Nervous System, Atypical Teratoid Rhabdoid Tumor, Recurrent Medulloblastoma, Papillary Tumor of the Pineal Region (High-grade Only), Glioma, Recurrent High Grade, Gliomatosis cerebri, Embryonal Tumor With Multilayered Rosettes (ETMR), Pinealoma, Neuroblastoma. CNS, Glioblastoma, IDH-mutant, Medulloblastoma, Medulloblastoma, G3/G4, Glioblastoma Multiforme, Primitive neuroectodermal tumor, Ependymoma, NOS, WHO Grade III, Medulloblastoma, SHH-activated and TP53 Wildtype, Neuroepithelial Tumor, High Grade, Ependymoma, NOS, WHO Grade II, Glioma, Cancer, Astrocytoma, Medulloblastoma, Non-WNT Non-SHH, NOS, Choroid Plexus Carcinoma, Glioma, Diffuse Midline, H3K27M-mutant, Medulloblastoma, WNT-activated, Medulloblastoma, Group 3, Pineal Parenchymal Tumor of Intermediate Differentiation (High-grade Only), Medulloblastoma, Group 4, Medulloblastoma, Chromosome 9q Loss, Glioma, High Grade, Glioblastoma, IDH-wildtype, Ependymoma

Patients will be stratified by the molecular and histologic characteristics of their tumor to one of three treatment strata. STRATUM A: Combination Treatment: ribociclib and gemcitabine. Patient Population: Participants with a diagnosis of refractory or recurrent medulloblastoma (Group 3/4) or refractory or recurrent ependymoma (including: ependymoma, not otherwise specified (NOS), ...